What PELyon - Pharmaco Epidemiology Lyon does

Epimentis (doing business as PELyon - Pharmaco Epidemiology Lyon) is a Lyon-based B2B consulting firm specializing in real-world data (RWD) strategy and pharmaco-epidemiological studies. Founded in 2010, the company operates with a 16-person multidisciplinary team composed of pharmacists, project managers, epidemiologists, biostatisticians, data analysts, and a quality manager. The firm is ISO 9001 certified and is a member of AFCROs, the French association of clinical research organizations, where it actively participates in three working groups: Real World Data, AI and Clinical Research, and RSE (Corporate Social Responsibility).

The company delivers a portfolio of consulting services rather than a software product, organized around five core offerings: epidemiological studies (evaluating disease burden and care management strategies), pharmaco-epidemiological studies (medication usage patterns and outcomes), economic evaluations (cost-of-illness and cost-effectiveness), healthcare quality and regulatory assessments, and methodological assistance for study design and regulatory submissions. Its technical work is grounded in access to the French national health claims database (SNDS) via a partnership with CNAM (Caisse Nationale d'Assurance Maladie), which enables large-scale observational studies — for example, a 2025 observational study with Roche covering 16,003 patients on supplemental oxygen therapy in idiopathic pulmonary fibrosis.

Epimentis generates revenue through professional-services engagements sold directly to four primary customer segments: pharmaceutical and biomedical companies, healthcare structures, health authorities, and patient associations. Pricing is quote-based and not publicly disclosed. The firm's go-to-market relies on direct B2B sales, scientific publications in peer-reviewed journals (e.g., Bulletin du Cancer), conference presentations, and industry association activity. Its operating geography is centered in France with European exposure through partners such as Agoria (Belgium). Ownership is private, with no disclosed external funding, parent company, or M&A activity.

Name

PELyon - Pharmaco Epidemiology Lyon

Legal name

Epimentis

Website

https://pelyon.fr

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Epimentis (operating as PELyon - Pharmaco Epidemiology Lyon) is a Lyon, France-based B2B consulting firm founded in 2010 that delivers real-world data, pharmaco-epidemiological, and economic evaluation studies to pharmaceutical companies, healthcare structures, health authorities, and patient associations.

Ownership category

akta.pro rank

Product category

Pharmaco-Epidemiology Consulting Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)

Keywords

• Real-world data consulting
• Pharmaco-epidemiology studies
• Health economics research
• Epidemiological study services
• Healthcare data analytics

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Consulting Services: B2B professional consulting services in real-world data strategy and scientific communication for healthcare actors including pharmaceutical companies, healthcare structures, health authorities, and patient associations

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Epimentis (also operating as PELyon - Pharmaco Epidemiology Lyon) is a B2B consulting firm that conducts pharmaco-epidemiological, epidemiological, and economic studies using real-world health data. The firm serves pharmaceutical and biomedical companies, healthcare structures, health authorities, and patient associations with services spanning study design, data analysis, methodological assistance, and scientific communication.

Product overview

Epimentis operates as a consulting services firm specializing in real-world health data strategy and communication. Rather than offering a unified software platform, the company provides a portfolio of specialized consulting services including epidemiological studies, pharmaco-epidemiological studies, economic studies, evaluations, and methodological assistance. These services are designed to help pharmaceutical companies, healthcare structures, health authorities, and associations make evidence-based strategic decisions regarding healthcare products and programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Epidemiological Studies (Études épidémiologiques)

Quantifiable outcome

• Published scientific articles in peer-reviewed journals including Bulletin du Cancer

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered minor and core.

• AgoriaminorStrategic or Co-development PartnerPartner organization shown in partnerships section. Agoria is a Belgian consortium supporting innovation in healthcare sector.
• LYSARCminorStrategic or Co-development PartnerPartner organization shown in partnerships section. LYSARC is a French cancer research organization.
• SancareminorStrategic or Co-development PartnerPartner organization shown in partnerships section. Sancare is a French healthcare data company.
• AFCROscoreStrategic or Co-development PartnerProfessional membership organization for clinical research. Epimentis participates in 3 working groups: Real World Data, AI and Clinical Research, RSE (Corporate Social Responsibility).

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Alcimed: French innovation and new-market consulting firm with a dedicated healthcare and life sciences practice serving pharma, medtech, and public health actors in France and internationally. Comparable boutique-services positioning.
• Heva: French health economics and real-world evidence consultancy with similar scope to Epimentis: pharmaco-epidemiology, HEOR, and disease burden studies for pharma/biotech clients across European markets.
• CEMKA: French health economics and pharmaco-epidemiology consultancy based near Paris. Provides RWE, HEOR, and real-world data studies for pharmaceutical companies and health authorities — a near-perfect size and geography match to Epimentis.
• Amaris Consulting: International consulting firm headquartered in Geneva with a Life Sciences practice serving pharma and biomedical clients across Europe. Comparable niche consulting model with similar buyer profile.

Broad incumbents

• Charles River Associates: Global consulting firm with a Life Sciences practice providing HEOR, market access, and commercial strategy for pharma — overlapping with Epimentis on the buyer side and analytical approach.
• IQVIA: Global CRO and RWE leader with deep pharmaco-epidemiology, HEOR, and real-world data capabilities. Competes with Epimentis for French and European RWE mandates, but at vastly greater scale and with proprietary technology.
• Parexel: Global CRO with real-world evidence, pharmaco-epidemiology, and regulatory-grade study capabilities serving pharma clients worldwide. Larger-scale competitor for the same buyer category.
• ICON plc: Global CRO with substantial real-world evidence and late-phase research capabilities (including via PRA Health Sciences and Mapi Group acquisitions). A direct competitor in RWE consulting but with global scale far beyond Epimentis.
• BearingPoint: European-origin management and technology consultancy with a strong healthcare and life sciences practice. Competes for similar pharmaceutical and health authority consulting engagements, though with broader scope.

Emerging players

• Sancare: French healthcare data company already partnered with Epimentis. Operates in the adjacent data-infrastructure layer of the RWE value chain — comparable market and complementary offerings that position them as collaborators and emerging competitors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pelyon-pharmaco-epid%C3%A9miologie-lyon

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PELyon - Pharmaco Epidemiology Lyon